stella
beta
Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease — Stella
Recruiting
Back to Lupus Nephritis trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Tongji Hospital, Wuhan, Hubei
View full record on ClinicalTrials.gov